Table 2. Hepatobiliary cancer patients’ characteristics, classification, and markers.
| Characteristics | Liver (n=80) | Gallbladder/biliary (n=11) |
|---|---|---|
| Gender (male/female, %) | 59 (73.8)/21 (26.3) | 3 (27.3)/8 (72.7) |
| Median age (years) | 59 [24–86] | 59 [42–71] |
| Race (White/others, %) | 68 (85.0)/12 (15.0) | 10 (90.9)/1 (9.1) |
| Median BMI | 28.3 (17.3–49.7) | 30 (20.7–37.8) |
| Cirrhosis (yes/no, %) | 27 (33.8)/53 (66.2) | 0 (0)/11 (100) |
| Median pain rating | 2 (0–9) | 4 (0–7) |
| Uncontrolled pain (yes/no, %) | 50 (62.5)/30 (37.5) | 577 (63.6)/4 (36.4) |
| Treatment (%) | ||
| None | 19 (23.8) | 0 (0) |
| Monotherapy | 48 (60.0) | 5 (45.5) |
| Combination therapy | 13 (16.3) | 6 (54.5) |
| Median IL-6 (pg/mL) | 17.7 (3.1–140.4) | 13.5 (3.1–33.6) |
| ECOG (%) | ||
| 0 | 25 (31.3) | 3 (27.3) |
| 1 | 36 (45) | 7 (63.6) |
| 2 | 14 (17.5) | 1 (9.1) |
| 3 | 5 (6.3) | 0 (0) |